Does PALBOCICLIB Cause Hypersomnia? 221 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 221 reports of Hypersomnia have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
221
Reports of Hypersomnia with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
13
Deaths
52
Hospitalizations
How Dangerous Is Hypersomnia From PALBOCICLIB?
Of the 221 reports, 13 (5.9%) resulted in death, 52 (23.5%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Hypersomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 221 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Hypersomnia?
PIMAVANSERIN (602)
ADALIMUMAB (467)
LENALIDOMIDE (401)
QUETIAPINE (394)
PREGABALIN (347)
TREPROSTINIL (317)
RISPERIDONE (302)
ARIPIPRAZOLE (286)
DULOXETINE (285)
OXYCODONE (280)
Which PALBOCICLIB Alternatives Have Lower Hypersomnia Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID